Alprostadil

Active ingredient description

Alprostadil is chemically identical to prostaglandin E1, the actions of which include vasodilatation of blood vessels in the erectile tissues of the corpora cavernosa and increase in cavernosal artery blood flow, causing penile rigidity.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
C01EA01
Alprostadil
C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EA Prostaglandins
Discover more medicines within C01EA01
G04BE01
Alprostadil
G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
MUSE Urethral Stick
Summary of Product Characteristics (SPC)
UK
PROSTIN VR Concentrate for solution for infusion
Summary of Product Characteristics (SPC)
UK
CAVERJECT Powder for solution for injection
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₂₀H₃₄O₅
Molecular mass: 354.487 g/mol

3D molecular structure

3D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 745-65-3
DrugBank Drug: DB00770
KEGG Drug: D00180
PubChem Compound: 5280723
RxNorm Ingredient: 598
SNOMED-CT Concept: 386972003
Alprostadil (substance)
SNOMED-CT Concept: 48988008
Alprostadil (substance)
UNII Identifier: F5TD010360
ALPROSTADIL

Medicines

Alprostadil is an active ingredient of these brands:

United States (US)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.

 
Next: Usage >